iPAG
Who is iPAG?
iPAG Position Statement
Diabetes
What is Type 1 Diabetes?
Type 2 Diabetes
Gestational Diabetes
MODY – Maturity onset diabetes of the young
Insulin Pump Therapy
Pumps available in Scotland & the UK
Comparison chart of all pumps available in the UK 2016
Insulin Pump and Continuous Glucose Monitor contracts NHS Scotland 2018
Benefits and disadvantages of insulin pump therapy
Getting a pump in Scotland
Healthboard Post-Warranty Insulin Pump Replacement Policy
CGM
Continuous glucose monitoring in the UK
Getting Continuous Glucose Monitoring in Scotland
NICE guidelines & funding CGM
Dexcom G5
Search
Tuesday, June 19, 2018
Blog
Useful info
Contact iPAG
iPAG Scotland
iPAG
Who is iPAG?
iPAG Position Statement
Diabetes
What is Type 1 Diabetes?
Type 2 Diabetes
Gestational Diabetes
MODY – Maturity onset diabetes of the young
Insulin Pump Therapy
Pumps available in Scotland & the UK
Comparison chart of all pumps available in the UK 2016
Insulin Pump and Continuous Glucose Monitor contracts NHS Scotland 2018
Benefits and disadvantages of insulin pump therapy
Getting a pump in Scotland
Healthboard Post-Warranty Insulin Pump Replacement Policy
CGM
Continuous glucose monitoring in the UK
Getting Continuous Glucose Monitoring in Scotland
NICE guidelines & funding CGM
Dexcom G5
Studies
Studies
The COMISAIR Study shows positive results for MDI patients on CGM
Mortality in Type 1 Diabetes
adAPT study – Type 1 Diabetes Prevention Trial
CSII users face almost 50% less risk of heart disease
Better control on a pump when used as first course of...
Study: Insulin Pump Better Than Injections
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
